SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 452.00
arrow_downward
-1.40%(-6.40) 1H
22 Okt, 5:29:32 PTG GMT+2 · SEK
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk SOBI...
Buka
SEK 448.00
Tinggi
SEK 454.40
Rendah
SEK 444.40
Permodalan Pasaran
161.65B
Purata volum
272.18K
Volum
0.00
Nisbah H/P
120.72
tgi 52 mgu
SEK 487.00
rdh 52 mgu
SEK 310.60
EPS
SEK 3.74
Syer tertunggak
357.64J
Bilangan pekerja
2K
Buka
SEK 448.00
Tinggi
SEK 454.40
Rendah
SEK 444.40
Permodalan Pasaran
161.65B
Purata volum
272.18K
Volum
0.00
Nisbah H/P
120.72
tgi 52 mgu
SEK 487.00
rdh 52 mgu
SEK 310.60
EPS
SEK 3.74
Syer tertunggak
357.64J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
www.marketscreener.com
·
9 minit lalu
S&P 500, Nasdaq end lower as revived AI doubts spark tech selloff
24/7 Wall St.
·
1 jam lalu
3 Vanguard ETFs Pay Up to 3.71%, and One Is Beating the S&P 500
Investor's Business Daily
·
42 minit lalu
Nasdaq's Stock Soars To New High, Leads 10 To Best Stock Lists While Its Index Plunges
Profil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Perihal Swedish Orphan Biovitrum AB (publ)